Retractable Technologies (RVP) Change in Accured Expenses (2010 - 2026)
Retractable Technologies (RVP) posted Change in Accured Expenses of $793609.0 for Q1 2026, up 236.68% on a QoQ basis from -$580648.0 in Q4 2025, and up 187.69% year-over-year from $275860.0 in Q1 2025.
Retractable Technologies (RVP) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Retractable Technologies' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $793609.0 for Q1 2026.
- Quarterly Change in Accured Expenses rose 187.69% year-over-year to $793609.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $472081.0 (up 2.1% YoY) and the FY2025 annual result came in at -$45668.0, up 66.49% from the prior year.
- Change in Accured Expenses was $793609.0 for Q1 2026 at Retractable Technologies, up from -$580648.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $793609.0 in Q1 2026 and bottomed at -$2.5 million in Q2 2022.
- A 5-year average of -$215098.6 and a median of $20556.0 in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses sank 7935.84% — and 2025, when it surged 599.96%.
- Retractable Technologies' Change in Accured Expenses stood at -$1.2 million in 2022, then decreased by 3.29% to -$1.2 million in 2023, then soared by 77.14% to -$283618.0 in 2024, then plunged by 104.73% to -$580648.0 in 2025, then soared by 236.68% to $793609.0 in 2026.
- Business Quant data shows RVP's Change in Accured Expenses at $793609.0 in Q1 2026, -$580648.0 in Q4 2025, and $115236.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.02 Bn | 120.80 Bn | 1.96 Bn | -260.40 Mn |
| 2 | Becton Dickinson | 44.98 Bn | 44.16 Bn | 2.15 Bn | - |
| 3 | Alcon | 33.07 Bn | 31.41 Bn | 1.53 Bn | - |
| 4 | Medline | 33.03 Bn | 30.80 Bn | 1.84 Bn | -32.00 Mn |
| 5 | Resmed | 29.47 Bn | 27.81 Bn | 890.98 Mn | 103.88 Mn |
| 6 | West Pharmaceutical Services | 23.28 Bn | 22.84 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -151.00 Mn |
| 8 | Cooper Companies | 13.93 Bn | 13.79 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.10 Bn | 11.04 Bn | 736.59 Mn | 5.38 Mn |
| 10 | Retractable Technologies | 20.36 Mn | -15.26 Mn | -838,408.00 | 793,609.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 793,609.00 |
| Mar 31, 2026 | 793,609.00 |
| Dec 31, 2025 | -580,648.00 |
| Dec 31, 2025 | -580,648.00 |
| Sep 30, 2025 | 115,236.00 |
| Sep 30, 2025 | 115,236.00 |
| Jun 30, 2025 | 143,884.00 |
| Jun 30, 2025 | 143,884.00 |
| Mar 31, 2025 | 275,860.00 |
| Mar 31, 2025 | 275,860.00 |
| Dec 31, 2024 | -283,618.00 |
| Dec 31, 2024 | -283,618.00 |
| Sep 30, 2024 | 449,554.00 |
| Sep 30, 2024 | 449,554.00 |
| Jun 30, 2024 | 20,556.00 |
| Jun 30, 2024 | 20,556.00 |
| Mar 31, 2024 | -322,754.00 |
| Mar 31, 2024 | -322,754.00 |
| Dec 31, 2023 | -1.24 Mn |
| Dec 31, 2023 | -1.24 Mn |